British Thoracic Society Sarcoidosis study: Effects of long term corticosteroid treatment

Thorax

Volumn 51, Issue 3, 1996, Pages 238-247

  Gibson, G J ^a,b   Prescott, R J ^a   Muers, M F ^a   Middleton, W G ^a   Mitchell, D N ^a   Connolly, C K ^a   Harrison, B D W ^a  

^a BRITISH THORACIC SOCIETY   (United Kingdom)

^b FREEMAN HOSPITAL   (United Kingdom)

Author keywords

Corticosteroids; Long term outcome; Sarcoidosis

Indexed keywords

CORTICOSTEROID; PREDNISOLONE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; LUNG FUNCTION; LUNG SARCOIDOSIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; GREAT BRITAIN; HUMANS; LUNG; MALE; PREDNISOLONE; RESPIRATORY FUNCTION TESTS; SARCOIDOSIS, PULMONARY; SOCIETIES, MEDICAL; TREATMENT OUTCOME;

EID: 0029869222     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.51.3.238     Document Type: Article

References (18)

1. Refvem O. Long-term corticosteroid treatment of pulmonary sarcoidosis. In: Iwai K, Hosoda Y, eds. Proceedings of the Sixth International Conference on Sarcoidosis. Baltimore: University Park Press, 1974:547-50.
2. De Remee RA. The present status of treatment of pulmonary sarcoidosis: a house divided. Chest 1977;71:388-93.
3. Scadding JG. Prognosis of intrathoracic sarcoidosis in England: a review of 136 cases after five years' observation. BMJ 1961;2:1165-72.
4. Colp C. Sarcoidosis: course and treatment. Med Clin North Am 1977;61:1267-78.
5. Israel HL, Fouts DW, Beggs RA. A controlled trial of prednisone treatment of sarcoidosis. Am Rev Respir Dis 1973;107:609-14.
6. Young RL, Harkleroad LE, Lordon RE, Weg JG. Pulmonary sarcoidosis: a prospective evaluation of glucocorticoid therapy. Ann Intern Med 1970;73:207-12.
7. Harkleroad LE, Young RL, Savage PJ, Jenkins DW, Lordon RE. Pulmonary sarcoidosis: long term follow up of the effects of steroid therapy. Chest 1982;82:84-7.
8. Hapke EJ, Meek JC. Steroid treatment in pulmonary sarcoidosis. In: Proceedings of the 5th International Conference on Sarciridosis. Prague: Universita Karlova, 1969:621-5.
9. Mikami R, Hiraga Y, Iwai K, Kosuda T, Mochizuki H, Homma H, et al. A double-blind controlled trial on the effect of corticosteroid therapy in sarcoidosis. In: Iwai K, Horsoda Y, eds. Proceedings of the 6th International Conference on Sarcoidosis. Baltimore: University Park Press, 1974:533-8.
10. Selroos O, Sellergren T-L. Corticosteroid therapy of pulmonary sarcoidosis. Scand J Respir Dis 1979;60:215-21.
11. Yamamoto M, Saito N, Tachibana T, Hiraga Y, Horikawa M, Osada H, et al. Effects of 18 month corticosteroid therapy on stage I and stage II sarcoidosis patients. In: Proceedings of the 9th International Conference on Sarcoidosis. Pergamon, 1983:470-4.
12. Eule H, Weinecke A, Roth I. The possible influence of corticosteroid therapy on the natural course of pulmonary sarcoidosis. Ann NY Acad Sci 1986;465:695-701.
13. Zaki M, Lyons HA, Leilop L, Huang C-T. Corticosteroid therapy in sarcoidosis: a five year controlled follow-up study. N Y State J Med 1987;87:496-9.
14. Quanjer PH. Standardised lung function testing. Clin Respir Physiol 1983;19(Suppl 5).
15. James DG, Carstairs LS, Trowell J, Sharma OP. Treatment of sarcoidosis. Lancet 1967;ii:526-8.
16. Johns CJ, Zachary JB, Ball WC. A ten year study of cortico-steroid treatment for pulmonary sarcoidosis. Johns Hopkins Med J 1974;134:271-83.
17. Douglas JG, Middleton WG, Gaddie J, Petrie GR, Choo-Kang YFJ, Prescott RJ, et al. Sarcoidosis: a disorder commoner in non-smokers. Thorax 1986;41:787-91.
18. Harrison BDW, Shaylor JM, Stokes TC, Wilkes AR. Airflow-limitation in sarcoidosis - a study of pulmonary function in 107 patients with newly diagnosed disease. Respir Med 1991;85:59-64.